Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
BJOG ; 126(1): 96-104, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30092615

ABSTRACT

OBJECTIVE: To determine which descriptors of cytoreductive surgical extent in advanced ovarian cancer (AOC) best predict postoperative morbidity. DESIGN: Retrospective notes review. SETTING: A gynaecological cancer centre in the UK. POPULATION: Six hundred and eight women operated on for AOC over a period of 114 months at a tertiary cancer centre, between 16 August 2007 and 16 February 2017. METHODS: Outcome data were analysed by six approaches to classify the extent of surgery: standard/ultra-radical surgery; standard/radical/supra-radical surgery; presence/absence of gastrointestinal resections; low/intermediate/high surgical complexity score (SCS); presence of bowel anastomoses and/or diaphragmatic surgery; and the presence/absence of multiple bowel resections. MAIN OUTCOME MEASURES: Major (grades 3-5) postoperative morbidity and mortality. RESULTS: Forty-three (7.1%) patients experienced major complications. Grade-5 complications occurred in six patients (1.0%). Patients who underwent multiple bowel resections had a relative risk (RR) of 7.73 (95% confidence interval, 95% CI 3.92-15.26), patients with a high SCS had an RR of 6.12 (95% CI 3.25-11.52), patients with diaphragmatic surgery and gastrointestinal anastomosis had an RR of 5.57 (95% CI 2.65-11.72), patients with 'any gastrointestinal resection' had an RR of 4.69 (95% CI 2.66-8.24), patients with ultra-radical surgery had an RR of 4.65 (95% CI 2.26-8.79), and patients with supra-radical surgery had an RR of 4.20 (95% CI 2.35-7.51) of grades 3-5 morbidity, compared with patients undergoing standard surgery as defined by the National Institute for Health and Care Excellence (NICE) in the UK. No significant difference was seen in the rate of major morbidity between standard (6/59, 10.2%) and ultra-radical (9/81, 11.1%) surgery within the cohort who had intermediate complex surgery (P > 0.05). CONCLUSIONS: The numbers of procedures performed significantly correlate with major morbidity. The number of procedures performed better predicted major postoperative morbidity than the performance of certain 'high risk' procedures. We recommend using SCS to define a higher risk operation. NICE should re-evaluate the use of the term 'ultra-radical' surgery. TWEETABLE ABSTRACT: Multiple bowel resection is the best predictor of morbidity and is more predictive than 'ultra-radical surgery'.


Subject(s)
Outcome Assessment, Health Care , Ovarian Neoplasms/surgery , Postoperative Complications/epidemiology , Aged , Cytoreduction Surgical Procedures/adverse effects , Cytoreduction Surgical Procedures/classification , Digestive System Surgical Procedures/adverse effects , Digestive System Surgical Procedures/classification , Female , Humans , Middle Aged , Morbidity , Ovarian Neoplasms/epidemiology , Postoperative Period , Retrospective Studies , Risk Factors
2.
J Obstet Gynaecol ; 33(8): 892-7, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24219737

ABSTRACT

Between March 2007 and December 2009, 38 patients underwent sentinel lymph node biopsy (SLNB) sampling, along with vulvectomy, in their management of vulval cancer. A review has been conducted to establish the reliability and accuracy of the new procedure compared with the traditional total inguinofemoral lymphadenectomy. We also aimed to establish both the short- and long-term morbidities of both total inguinofemoral lymphadenectomy and SLNB and to assess the duration of hospital stay in both groups. Our data have shown a reduced short- and long-term morbidity and reduced length of hospital stay for the SLNB procedure. We conclude that it is a reliable and safe procedure, however it should only be conducted in cancer centres.


Subject(s)
Carcinoma, Squamous Cell/surgery , Sentinel Lymph Node Biopsy , Vulvar Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Female , Humans , Lymph Nodes/pathology , Middle Aged , Retrospective Studies , United Kingdom/epidemiology , Vulvar Neoplasms/mortality , Vulvar Neoplasms/pathology
3.
J Obstet Gynaecol ; 30(4): 408, 2010 May.
Article in English | MEDLINE | ID: mdl-20455728
4.
Br J Cancer ; 101(3): 498-503, 2009 Aug 04.
Article in English | MEDLINE | ID: mdl-19623182

ABSTRACT

BACKGROUND: Epidemiological and in vitro data implicate androgens in the aetiology of ovarian cancer, but the mechanisms by which this is mediated are unclear. In this study, we wished to examine the effects of androgens on gene expression in ovarian cancer. METHODS: The expression of androgen receptor (AR) in OVCAR3 and OSEC2 cells was confirmed using immunoblotting and response to androgens was measured using flow cytometric assessment of S-phase fraction. The differential gene expression between androgen stimulated and unstimulated OVCAR3 ovarian cancer cells was examined with a cDNA microarray. The upregulation of a subset of these genes was then confirmed with reverse transcriptase PCR in both OVCAR3 and OSEC2, an ovarian epithelial cell line. Finally, the clinical significance of this upregulation was investigated by examining the expression of Rab25 and Rab35, two G-protein-related molecules in an ovarian cancer tissue microarray (TMA). RESULTS: OVCAR3 and OSEC2 cells were shown to express the AR and showed an increase in S-phase fraction in response to androgen treatment. Treatment of OVCAR3 cells with androgen resulted in a significant upregulation of 121 genes. These findings were confirmed for a subset of seven monomeric G-protein-related genes in both OVCAR3 and OSEC2 cells. After staining for Rab25 and Rab35, the majority of TMA sections examined showed expression for Rab25 (92%) and Rab35 (95%). The expression of Rab25 correlated with histological grade, and expression was higher in endometrioid (median histoscore 10.5) than serous (7.5) or mucinous (5.3) tumours. The expression of Rab25 correlated positively with AR expression supporting its role as an androgen responsive gene in ovarian cancer. CONCLUSIONS: These results suggest that androgens can effect expression of the oncogenic GTPases in ovarian cancer. We propose that the androgen responsive Rab35 may have clinical importance as a biomarker of AR function.


Subject(s)
Dihydrotestosterone/pharmacology , Ovarian Neoplasms/metabolism , rab GTP-Binding Proteins/genetics , Cell Line, Tumor , Female , Humans , Ovarian Neoplasms/pathology , RNA, Messenger/analysis , Receptors, Androgen/genetics , Tissue Array Analysis
5.
J Obstet Gynaecol ; 28(1): 73-6, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18259904

ABSTRACT

On average, the length of time women remain in hospital after giving birth in the UK has deceased in recent years but most women are nevertheless admitted to a postnatal ward after childbirth. In this unique, prospective, observational study, we drew upon the expertise of caregivers on postnatal wards to reveal a wide range of obstetric, medical, neonatal and social problems that can lead to prolonged hospital stay. A woman's stay was likely to be increased by the greatest amount if her baby required specialised care but bed occupancy was more strongly influenced by the presence of obstetric complications because these were common. In this paper, we describe inpatient postnatal activity in detail and make recommendations for the safe and effective development of postnatal services.


Subject(s)
Bed Occupancy/statistics & numerical data , Delivery, Obstetric/statistics & numerical data , Length of Stay , Obstetrics and Gynecology Department, Hospital/statistics & numerical data , Postnatal Care , Puerperal Disorders/epidemiology , England/epidemiology , Female , Hospitals/statistics & numerical data , Humans , Postpartum Period , Pregnancy , Prevalence , Prospective Studies , Puerperal Disorders/etiology , Puerperal Disorders/prevention & control , Risk Factors , State Medicine/statistics & numerical data
6.
Acta Neurol Scand ; 113(1): 46-54, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16367899

ABSTRACT

OBJECTIVE: Acetyl choline (ACh) is the main neurotransmitter of the efferent auditory system. This study is aimed to evaluate cochlear function in myasthenia gravis (MG), a neuromuscular transmission disorder caused by ACh receptor autoantibodies. METHODS: This prospective study included 16 myasthenic patients, tested audiologically twice, first after improvement from myasthenic crisis or acute oropharyngeal dysfunction (1 week from admission) and then 2 months later. We detected the effect of contralateral acoustic stimulation (CAS) on patients' transient and distortion product otoacoustic emissions (TEOAE and DPOAE). RESULTS: Compared with controls, patients reported significant reduction in overall echo response and amplitude of TEOAEs at 1-2 kHz and at 1-6 kHz of DPOAE with marked reduction at 5 kHz. In the control group, CAS produced amplitude reduction in TEOAEs and DPOAEs at 1-4 kHz. Utilizing masking effect, patients reported amplitude reduction in TEOAEs at 1.5-4 kHz while DPOAEs did not reach significant level except at 1.5 and 5 kHz. After 2 months, no changes were observed compared with early assessment. CONCLUSIONS: It is clear that disease progression is associated with irreversible cochlear damage. Lack of improvement in patients' emissions despite partial non-audiometric improvement in relation to receptors needs to be considered.


Subject(s)
Cochlea/physiopathology , Diagnostic Techniques, Otological , Hearing Loss, Sensorineural/diagnosis , Myasthenia Gravis/complications , Otoacoustic Emissions, Spontaneous , Adolescent , Adult , Auditory Threshold , Chronic Disease , Cochlea/pathology , Female , Follow-Up Studies , Hearing Loss, Sensorineural/etiology , Hearing Loss, Sensorineural/physiopathology , Humans , Male , Middle Aged , Myasthenia Gravis/physiopathology , Prospective Studies
7.
Science ; 196(4294): 1093-4, 1977 Jun 03.
Article in English | MEDLINE | ID: mdl-17778546

ABSTRACT

Catalytic reactions of carbon monoxide with hydrogen have been studied in which intermetallic compounds of the formula MNi(5) (where M is thorium, uranium, or zirconium) have been used as the catalysts. The materials perform effectively as methanation catalysts; ThNi(5) has a specific activity exceeding that of a typical commercial oxide-supported methanation catalyst by a factor of about 5. This material also shows superior resistance to hydrogen sulfide poisoning. Nickel, formed as a decomposition product of the MNi(5) intermetallic compound, is probably the active species, but its properties are influenced by the nature of M in the precursor MNi(5) system.

SELECTION OF CITATIONS
SEARCH DETAIL